Enhabit concludes strategic review without sale; Q1 rev $262.4M, Adj. EBITDA $25.3M

Enhabit, Inc.

Board ends strategic alternatives review, will remain independent; no formal proposals received.
Q1 net income $0.2M, diluted EPS $0.01; adjusted EPS $0.07.
Total admissions up 5.3% YoY; non-Medicare home health admissions up 25.2%.
Reaffirms FY 2024 guidance: revenue $1.076-1.102B, Adj. EBITDA $98-110M.
Four legacy Encompass board members to not stand for election in 2024, reducing board to 9.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Enhabit, Inc. reported the quarter ended March 31, 2024 results: revenue $262.4 million, net income $0.2 million, EPS $0.01. Guidance reaffirmed.

Period: the quarter ended March 31, 2024
Revenue: $262.4 million
Net income: $0.2 million
EPS: $0.01
Guidance: reaffirmed
Result: reported results

Exact text from the filing

in both the first quarter of 2024 and 2023. We are confident we are taking the right steps to drive future growth.” QUARTERLY PERFORMANCE - CONSOLIDATED • Net service revenue of $262.4 million • Net income attributable to Enhabit, Inc. of $0.2 million • Adjusted EBITDA of $25.3 million • Earnings per share of $0.01 • Adjusted earnings per share of $0.07 RECENT COMPANY

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Enhabit, Inc. filing history →

Source: SEC EDGAR

accession 0001803737-24-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.